This Article Full Text Full Text (PDF) Correction (v67,p10097) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zheng, X. Articles by Liu, W. Search for Related Content PubMed PubMed Citation Articles by Zheng, X. Articles by Liu, W.

Most C6 Cells Are Cancer Stem Cells: Evidence from Clonal and Population Analyses

¹ First Affiliated Hospital, School of Medicine and ² Institute of Brain Medicine, Zhejiang University, Hangzhou, China

Requests for reprints: Xiaofeng Yang, Institute of Brain Medicine, First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou 310009, China. Phone: 86-571-87784606; Fax: 86-571-87783757; E-mail: pheiphei{at}163.com.

Cancer stem cells have been isolated from human gliomas and many other parenchymal tumors. It was previously assumed that many established malignant cell lines also contain a rare subpopulation of stem cells. This study was designed to investigate the fraction of cancer stem cells in the C6 glioma cell line using clonal and population analyses, rather than isolating methods, which are based on specific markers. Interestingly, in the serum-containing medium, each of the 67 single C6 cells plated per miniwell was able to generate a clone and subclones, which subsequently gave rise to a xenograft glioma in the BALB/C-nude mouse. The CD133^– C6 cells also possessed clonogenic, self-renewal, and tumorigenic capacities. Moreover, our findings indicated that brief exposure to Hoechst 33342 was harmful to the clonogenicity and proliferation of individual C6 cells. Therefore, the non–side-population cells may be deprived of their stem cell features in the process of Hoechst 33342 staining as a step in isolating a Hoechst-negative side population with flow cytometry. Thus, we concluded that the C6 line was mainly composed of cancer stem cells, although many of them were neither CD133⁺ nor side population. [Cancer Res 2007;67(8):3691–7]

This article has been cited by other articles:

				F. Barbieri, A. Pattarozzi, M. Gatti, C. Aiello, A. Quintero, G. Lunardi, A. Bajetto, A. Ferrari, M. D. Culler, and T. Florio Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1078 - E1088. [Abstract] [Full Text] [PDF]

				G. Stoica, G. Lungu, H. Martini-Stoica, S. Waghela, J. Levine, and R. Smith Identification of Cancer Stem Cells in Dog Glioblastoma Vet. Pathol., May 1, 2009; 46(3): 391 - 406. [Abstract] [Full Text] [PDF]

				M. Jaksch, J. Munera, R. Bajpai, A. Terskikh, and R. G. Oshima Cell Cycle-Dependent Variation of a CD133 Epitope in Human Embryonic Stem Cell, Colon Cancer, and Melanoma Cell Lines Cancer Res., October 1, 2008; 68(19): 7882 - 7886. [Abstract] [Full Text] [PDF]

				S. Sell and H. L. Leffert Liver Cancer Stem Cells J. Clin. Oncol., June 10, 2008; 26(17): 2800 - 2805. [Abstract] [Full Text] [PDF]

				H. Li, X. Chen, T. Calhoun-Davis, K. Claypool, and D. G. Tang PC3 Human Prostate Carcinoma Cell Holoclones Contain Self-renewing Tumor-Initiating Cells Cancer Res., March 15, 2008; 68(6): 1820 - 1825. [Abstract] [Full Text] [PDF]

				F. B. Furnari, T. Fenton, R. M. Bachoo, A. Mukasa, J. M. Stommel, A. Stegh, W. C. Hahn, K. L. Ligon, D. N. Louis, C. Brennan, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment Genes & Dev., November 1, 2007; 21(21): 2683 - 2710. [Abstract] [Full Text] [PDF]

				Correction: Analysis of the C6 Glioma Cell Line Cancer Res., October 15, 2007; 67(20): 10097 - 10097. [Full Text] [PDF]

				J. N. Rich Cancer Stem Cells in Radiation Resistance Cancer Res., October 1, 2007; 67(19): 8980 - 8984. [Abstract] [Full Text] [PDF]

				S. E. Kern and D. Shibata The Fuzzy Math of Solid Tumor Stem Cells: A Perspective Cancer Res., October 1, 2007; 67(19): 8985 - 8988. [Abstract] [Full Text] [PDF]